Atlas Trials

High Dose Interval Vitamin D Supplementation in Patients With IBD Receiving Remicade

Clinical trial NCT03162432 · UNKNOWN

Trial details

NCT number
NCT03162432
Sponsor
Boston Children's Hospital
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
IBDUlcerative ColitisCrohn Disease
Start date
2017-08-01
Primary completion
2023-12-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.